Literature DB >> 19428544

Knee resistance during passive stretch in patients with hypertonia.

Maria K Lebiedowska1, John R Fisk.   

Abstract

The aims of the study were to determine by a portable method (1) whether velocity-dependent changes in knee resistance in patients with spastic paresis differ from those in non-disabled subjects, and (2) whether biomechanical measures of resistance can differentiate between neural and other factors that contribute to hypertonia (increased resistance). Biomechanical (hand-hold dynamometer, electrogoniometer) and bioelectrical (EMG) measures of resistance were evaluated under static (slow stretch) and dynamic (fast stretch) conditions in twenty patients with hypertonia and 19 non-disabled subjects. Measures calculated for non-disabled subjects (control limbs) were compared to those calculated for patients (spastic limbs). Biomechanical measures of resistance did not differ strongly between groups of spastic and control limbs and between spastic limbs having different origins of knee hypertonia (neural vs. other), due to substantial variability. In contrary the static and dynamic bioelectrical measures of muscles activation were substantially larger in spastic limbs than in control limbs (p<0.05). The variability of biomechanical measures of resistance was due to varied patterns of muscle activation in response to stretch. We concluded that the biomechanical measures of hypertonia did not discriminate spastic patients from non-disabled subjects. To classify various types of knee hypertonia, the portable method should include not only analysis of biomechanical but also EMG characteristics of hypertonia. It is expected that the functional status of patients would be better predicted using clinical and quantitative measures of impairment if different classes of hypertonia (defined by different patterns of activation) were analyzed separately rather than analyzing the heterogeneous patient population as a whole.

Entities:  

Mesh:

Year:  2009        PMID: 19428544     DOI: 10.1016/j.jneumeth.2009.02.005

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  6 in total

1.  Comprehensive neuromechanical assessment in stroke patients: reliability and responsiveness of a protocol to measure neural and non-neural wrist properties.

Authors:  Hanneke van der Krogt; Asbjørn Klomp; Jurriaan H de Groot; Erwin de Vlugt; Frans Ct van der Helm; Carel Gm Meskers; J Hans Arendzen
Journal:  J Neuroeng Rehabil       Date:  2015-03-13       Impact factor: 4.262

2.  Muscle activation patterns when passively stretching spastic lower limb muscles of children with cerebral palsy.

Authors:  Lynn Bar-On; Erwin Aertbeliën; Guy Molenaers; Kaat Desloovere
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

3.  Upper limb robotic assessment: Pilot study comparing velocity dependent resistance in individuals with acquired brain injury to healthy controls.

Authors:  Nitin Seth; Denise Johnson; Brian Allen; Hussein A Abdullah
Journal:  J Rehabil Assist Technol Eng       Date:  2020-12-04

Review 4.  The gap between clinical gaze and systematic assessment of movement disorders after stroke.

Authors:  Hanneke J M van der Krogt; Carel G M Meskers; Jurriaan H de Groot; Asbjørn Klomp; J Hans Arendzen
Journal:  J Neuroeng Rehabil       Date:  2012-08-27       Impact factor: 4.262

5.  Neuro-musculoskeletal simulation of instrumented contracture and spasticity assessment in children with cerebral palsy.

Authors:  Marjolein Margaretha van der Krogt; Lynn Bar-On; Thalia Kindt; Kaat Desloovere; Jaap Harlaar
Journal:  J Neuroeng Rehabil       Date:  2016-07-16       Impact factor: 4.262

6.  The Relationship Between Medial Gastrocnemius Lengthening Properties and Stretch Reflexes in Cerebral Palsy.

Authors:  Lynn Bar-On; Barbara M Kalkman; Francesco Cenni; Simon-Henri Schless; Guy Molenaers; Constantinos N Maganaris; Alfie Bass; Gill Holmes; Gabor J Barton; Thomas D O'Brien; Kaat Desloovere
Journal:  Front Pediatr       Date:  2018-10-04       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.